An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for EDWARDS LIFESCIENCES Corp
| Ticker | EW |
| FIGI | BBG000BRXP69 |
| CUSIP | 28176E108 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 1226 / 17.4% |
| Percentage held by institutional investors | 80.6% |
About
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia